Equity and debt offerings as they're announced. https://quantisnow.com/news/offerings en-us Mon, 27 Apr 2026 19:42:35 GMT Beijing, China, April 27, 2026 (GLOBE NEWSWIRE) -- U-BX Technology Ltd. (NASDAQ:UBXG) (the "Company"), a leading company providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers, today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities at a combined offering price of $0.30 per Unit in a registered direct offering (the "Offering"). Each Unit consists of (i) one Class A ordinary share, par value $0.0016 per share (the "Class A Ordinary Shares"), and (ii) one warrant (each, a "Warrant") to purchase 0.3 of https://quantisnow.com/insight/u-bx-technology-ltd-announces-pricing-of-455-million-registered-direct-6516071 https://quantisnow.com/insight/u-bx-technology-ltd-announces-pricing-of-455-million-registered-direct-6516071 Mon, 27 Apr 2026 17:07:00 GMT Scottsdale, AZ, April 27, 2026 (GLOBE NEWSWIRE) -- Mark Davis, CEO of Black Rock Coffee Bar, has been recognized as a finalist for the 2026 EY Entrepreneur Of The Year® Pacific Southwest Award, Ernst & Young LLP (EY US) announced. Now in its 41st year, the EY Entrepreneur Of The Year program recognizes leaders who build high‑growth businesses, drive innovation and create long‑term value for employees, customers and communities. Davis was selected by an independent panel of judges based on his leadership, entrepreneurial vision, commitment to sustained growth, and the company's performance. "I'm honored to be named a finalist for EY Entrepreneur Of The Year in the Pacific Southwes https://quantisnow.com/insight/black-rock-coffee-bar-ceo-mark-davis-named-2026-ey-6516052 https://quantisnow.com/insight/black-rock-coffee-bar-ceo-mark-davis-named-2026-ey-6516052 Mon, 27 Apr 2026 16:55:18 GMT DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, the Company has agreed to issue to the investor unregistered Series A-1 warrants to purchase up to 696,866 shares of common stock and unregistered Series A-2 warrants to purchase up to 696,866 shares of common stock. The warrants will have an exercise price of $1.435 per share and will be exerci https://quantisnow.com/insight/amesite-announces-up-to-6-million-concurrent-registered-direct-offering-6516027 https://quantisnow.com/insight/amesite-announces-up-to-6-million-concurrent-registered-direct-offering-6516027 Mon, 27 Apr 2026 16:25:01 GMT SHANGHAI, April 27, 2026 /PRNewswire/ -- U Power Limited (NASDAQ:UCAR) (the "Company" or "U Power"), a provider of AI-integrated solutions for next-generation energy grids and intelligent transportation systems, today announced that on April 27, 2026, it entered into subscription agreements (the "Subscription Agreements") with ten purchasers, including Founder and Chief Executive Officer Johnny Lee, for the sale of 15,670,737 Class A Ordinary Shares (each, a "Share" and collectively, the "Shares") of the Company at $1.64 per Share, in reliance upon Regulation S under the Securities Act of 1933, as amended (the "Transaction"). Purchasers of the Shares also include Fortune Light Assets Ltd, a https://quantisnow.com/insight/u-power-limited-announces-private-placement-of-257-million-6515960 https://quantisnow.com/insight/u-power-limited-announces-private-placement-of-257-million-6515960 Mon, 27 Apr 2026 15:06:00 GMT DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST) (the "Company"), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a request for withdrawal of the Company's Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20, 2026 (the "Registration Statement"), as the Company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement. This https://quantisnow.com/insight/amesite-announces-withdrawal-of-registration-statement-on-form-s-1-6515881 https://quantisnow.com/insight/amesite-announces-withdrawal-of-registration-statement-on-form-s-1-6515881 Mon, 27 Apr 2026 13:30:00 GMT ORLANDO, Fla., April 27, 2026 /PRNewswire/ -- M-tron Industries, Inc. (NYSE:MPTI) ("Mtron" or the "Company"), a U.S.-based designer and manufacturer of highly-engineered electronic components and solutions for the aerospace and defense, avionics, and space industries, announced today the completion of its previously announced rights offering (the "Rights Offering"), which expired at 5:00 p.m., New York City time, on April 20, 2026. The Company received approximately $42.1 million in proceeds, which will be used to support its efforts to continue to increase earnings and shareholder return, and may also be used for potential acquisitions, strategic investments, investment in a strategic RF fu https://quantisnow.com/insight/m-tron-industries-inc-announces-completion-of-rights-offering-6515793 https://quantisnow.com/insight/m-tron-industries-inc-announces-completion-of-rights-offering-6515793 Mon, 27 Apr 2026 12:55:00 GMT NEWTOWN, Pa., April 27, 2026 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ:HSDT) ("HSDT" or the "Company"), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to acquiring and holding Solana tokens ("SOL"), today announced that it has entered into a definitive agreement providing for the purchase and sale of an aggregate of 3,076,922 shares of Class A common stock at a purchase price of $2.60 per share.   In addition, the Company entered into a put option agreement with the purchasers, pursuant to which the Company grants the purchasers the right, upon the occurrence of specified future events, to require the Company to repurchase all or a https://quantisnow.com/insight/solana-company-nasdaq-hsdt-announces-registered-direct-offering-of-common-6515702 https://quantisnow.com/insight/solana-company-nasdaq-hsdt-announces-registered-direct-offering-of-common-6515702 Mon, 27 Apr 2026 12:30:00 GMT HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of outstanding borrowings under its $4.000 billion commercial paper program (which may be reborrowed from time to time), and may use a portion of the net proceeds from this offering for the redemption of all or a portion of the $1.500 billion outstanding aggre https://quantisnow.com/insight/hca-announces-proposed-public-offering-of-senior-notes-6515678 https://quantisnow.com/insight/hca-announces-proposed-public-offering-of-senior-notes-6515678 Mon, 27 Apr 2026 12:24:00 GMT Nominees Keith Mestrich and Donald Felix Collectively Bring Backgrounds that Directly Align with Carver's Needs, Including Experience Transforming Financial Institutions and Driving Profitability and Growth Refreshment Delivers on Previously Announced Board Modernization Commitment and is a Critically Important Part of Positioning Carver for Sustainable Profitability and Growth Management and the Board Continue to Take Decisive Actions to Improve Performance and Enhance Value for All Stockholders Vote on the WHITE Proxy Card TODAY to Elect Carver's Two Highly Qualified Candidates – Keith Mestrich and Donald Felix – to the Board  NEW YORK, April 27, 2026 /PRNewswire/ -- Carver Bancorp, Inc. ( https://quantisnow.com/insight/carver-bancorp-inc-announces-slate-of-highly-qualified-director-candidates-6515589 https://quantisnow.com/insight/carver-bancorp-inc-announces-slate-of-highly-qualified-director-candidates-6515589 Mon, 27 Apr 2026 12:00:00 GMT FORT WORTH, Texas, April 27, 2026 (GLOBE NEWSWIRE) -- FirstCash Holdings, Inc. ("FirstCash" or the "Company") (NASDAQ:FCFS) today announced that the Company's wholly-owned subsidiary, FirstCash, Inc. (the "Issuer"), has commenced an offering through a private placement, subject to market and other conditions, of $600,000,000 in aggregate principal amount of senior notes due 2034 (the "Notes"). The Notes will be unsecured senior obligations of the Issuer and will be guaranteed by FirstCash and its domestic subsidiaries that guarantee its revolving unsecured credit facility and existing senior unsecured notes. FirstCash intends to use the proceeds from the offering to repay a portion of Fir https://quantisnow.com/insight/firstcash-announces-commencement-of-offering-of-senior-notes-6515512 https://quantisnow.com/insight/firstcash-announces-commencement-of-offering-of-senior-notes-6515512 Mon, 27 Apr 2026 11:49:59 GMT Warsaw, Poland and Taipei, Taiwan, April 27, 2026 (GLOBE NEWSWIRE) -- CADV Ventures S.A., an AI software company founded in 2017 and headquartered in Warsaw, Poland, focused on improving digital customer engagement for large organizations ("CADV.AI"), and Miluna Acquisition Corp (NASDAQ:MMTX) ("Miluna"), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement. Upon closing of the proposed business combination, the combined company will operate under the name Kukugan Corp., a Cayman Islands exempted company, and the combined company's ordinary shares and warrants are anticipated to be listed on a national securities exch https://quantisnow.com/insight/cadv-ventures-sa-to-combine-with-miluna-acquisition-corp-to-6515469 https://quantisnow.com/insight/cadv-ventures-sa-to-combine-with-miluna-acquisition-corp-to-6515469 Mon, 27 Apr 2026 11:30:00 GMT $225 million funded at closing, with an additional $225 million warrant tranche Financing funds operations through anticipated Phase 3 MASH 52-week data readout Financing was led by Deep Track Capital, with participation from TCGX, Viking Global Investors, RA Capital Management, and other new and existing investors GAITHERSBURG, Md., April 27, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the closing of its previously announced underwritten public offering consisting of (i) 64,250,000 shares of its common stock and 64,250,000 accompanying common stock warra https://quantisnow.com/insight/altimmune-announces-closing-of-225-million-oversubscribed-public-offering-of-6515382 https://quantisnow.com/insight/altimmune-announces-closing-of-225-million-oversubscribed-public-offering-of-6515382 Mon, 27 Apr 2026 11:00:00 GMT SINGAPORE, April 25, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (("BGIN" or the "Company", NASDAQ:BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today released its unaudited financial results for the year ended December 31, 2025. 2025 Financial Highlights Total Revenue was US$67.4 million compared to US$302.3 million in 2024.Net Loss was US$177.0 million compared to net income of US$66.1 million in 2024.  Management Commentary Mr. Allen Wu, Founder, Chief Executive Officer and Director of BGIN, commented: "2025 marked a deeply transformative year for BGIN. We made difficult but de https://quantisnow.com/insight/bgin-blockchain-limited-reports-unaudited-financial-results-for-the-full-6514918 https://quantisnow.com/insight/bgin-blockchain-limited-reports-unaudited-financial-results-for-the-full-6514918 Fri, 24 Apr 2026 21:00:00 GMT CRANFORD, N.J., April 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 5,076,143 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.985 per share (or pre-funded warrant in lieu thereof). In a concurrent private placement, the Company issued unregistered warrants to purchase up to 5,076,143 shares of common stock at an exe https://quantisnow.com/insight/citius-pharmaceuticals-announces-closing-of-registered-direct-offering-of-5-6514704 https://quantisnow.com/insight/citius-pharmaceuticals-announces-closing-of-registered-direct-offering-of-5-6514704 Fri, 24 Apr 2026 20:30:00 GMT HONG KONG, April 24, 2026 (GLOBE NEWSWIRE) -- DarkIris Inc. (NASDAQ:DKI) (the "Company" or "DarkIris"), a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games through various third-party digital storefronts, today announced the successful closing of a series of previously disclosed private placement and intellectual property (IP) assets acquisition. These include a $3.8 million private investment in public equity (PIPE) financing and an approximately $800,000 content acquisition of premium film and television IPs through equity issuance. Through these transactions, DarkIris has introduced key industry partners into its business e https://quantisnow.com/insight/darkiris-inc-announces-closing-of-38-million-pipe-financing-and-6514221 https://quantisnow.com/insight/darkiris-inc-announces-closing-of-38-million-pipe-financing-and-6514221 Fri, 24 Apr 2026 20:05:00 GMT AXT, Inc. (NASDAQ:AXTI) ("AXT" or the "Company"), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and other offering expenses. As previously announced, the Company intends to use the net proceeds from the offering primarily to financially support our subsidiary Beijing Tongme https://quantisnow.com/insight/axt-announces-exercise-of-over-allotment-option-in-public-offering-of-6513981 https://quantisnow.com/insight/axt-announces-exercise-of-over-allotment-option-in-public-offering-of-6513981 Fri, 24 Apr 2026 16:00:00 GMT NEW YORK, April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the closing of its previously announced underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share, anchored by a $15 million investment from a fundamental institutional investor with support from a large existing shareholder. The gross proceeds from the offering, before deducting underwriting discount https://quantisnow.com/insight/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-6513899 https://quantisnow.com/insight/lucid-diagnostics-announces-closing-of-18-million-underwritten-offering-of-6513899 Fri, 24 Apr 2026 14:23:00 GMT PORTLAND, Maine, April 24, 2026 (GLOBE NEWSWIRE) -- The Elmet Group Co. ("Elmet" or the "Company"), a U.S.-based provider of precision-engineered components and advanced high-energy systems, today announced the closing of its upsized initial public offering of an aggregate of approximately 9.9 million shares of its common stock, including the full exercise by the underwriters of their overallotment option to purchase approximately 1.3 million shares, at a public offering price of $14.00 per share. The aggregate net proceeds to Elmet from the offering were $125.5 million after deducting underwriting discounts and commissions and other offering expenses payable by Elmet. The shares began tra https://quantisnow.com/insight/the-elmet-group-co-announces-closing-of-upsized-initial-public-6513871 https://quantisnow.com/insight/the-elmet-group-co-announces-closing-of-upsized-initial-public-6513871 Fri, 24 Apr 2026 13:31:03 GMT BOULDER, Colo., April 24, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced the pricing of a best efforts public offering of an aggregate of 5,084,745 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 5,084,745 shares of common stock (the "Warrants"), at a combined public offering price of $2.36 per share (or per common stock equivalent in lieu thereof) and accompanying Warrant. The Warrants will have an exercise price of $2.36 https://quantisnow.com/insight/auddia-announces-pricing-of-12-million-public-offering-6513853 https://quantisnow.com/insight/auddia-announces-pricing-of-12-million-public-offering-6513853 Fri, 24 Apr 2026 13:15:00 GMT Trio-Tech International ("Trio-Tech" or the "Company") (NYSE:TRT), a comprehensive provider of semiconductor back-end solutions and a global value-added supplier of electronic equipment, today announced that it has entered into securities purchase agreements with fundamental institutional investors for the purchase and sale of 1,052,632 shares of its common stock in a registered direct offering (the "Offering"). The closing of the Offering is expected to occur on or about April 27, 2026, subject to the satisfaction of customary closing conditions. D. Boral Capital LLC is acting as exclusive placement agent for the Offering. The gross proceeds to the Company from the Offering are expecte https://quantisnow.com/insight/trio-tech-international-trt-announces-pricing-of-10-million-registered-direct-6513822 https://quantisnow.com/insight/trio-tech-international-trt-announces-pricing-of-10-million-registered-direct-6513822 Fri, 24 Apr 2026 13:00:00 GMT WILMINGTON, Mass., April 24, 2026 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. ("Liberty" or the "Company") (NASDAQ:DETX) (TSXV:SCAN) today announced the closing of its initial public offering in the United States of 3,673,638 common shares at a public offering price of $4.50 per share and to certain investors, in lieu of common shares, pre-funded warrants to purchase 770,807 common shares at a purchase price of $4.4999 per pre-funded warrant, which represented the public offering price per share, minus the $0.0001 per share exercise price of each such pre-funded warrant. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated of https://quantisnow.com/insight/liberty-defense-announces-closing-of-its-us-initial-public-offering-6513763 https://quantisnow.com/insight/liberty-defense-announces-closing-of-its-us-initial-public-offering-6513763 Fri, 24 Apr 2026 12:30:00 GMT CRANFORD, N.J., April 24, 2026 /PRNewswire/ -- Citius Pharmaceuticals Inc. (NASDAQ:CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into a definitive agreement for the purchase of an aggregate of 5,076,143 shares of its common stock  (or pre-funded warrants in lieu thereof) at a purchase price of $0.985 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company will issue unregistered warrants to purchase up to 5,076,143 shares of comm https://quantisnow.com/insight/citius-pharmaceuticals-announces-a-registered-direct-offering-of-5-million-6513657 https://quantisnow.com/insight/citius-pharmaceuticals-announces-a-registered-direct-offering-of-5-million-6513657 Fri, 24 Apr 2026 12:00:00 GMT Proposal Provides Stockholders $2.35 per Share in Cash, a 39% Premium to the Unaffected Closing Price, as Well as Potential Additional Value from the Sale of Seer's Assets via a Contingent Value Right Proposal Provides Stockholders Immediate and Significant Value While Avoiding Further Value Destruction from Continued Abysmal Operating Results Criticizes the Board for Failing to Engage With the Radoff-JEC Group Regarding its Acquisition Proposal Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group"), who collectively own approximately 7.6% of the outstanding shares of Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), today submitted t https://quantisnow.com/insight/the-radoff-jec-group-submits-improved-non-binding-proposal-to-acquire-seer-6513546 https://quantisnow.com/insight/the-radoff-jec-group-submits-improved-non-binding-proposal-to-acquire-seer-6513546 Fri, 24 Apr 2026 11:00:00 GMT /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TORONTO, April 23, 2026 /CNW/ - The Toronto-Dominion Bank ("TD" or the "Bank") today announced a domestic public offering of C$1 billion of medium term notes (non-viability contingent capital (NVCC)) constituting subordinated indebtedness of the Bank (the "Notes").  The Notes will be issued and sold through a dealer syndicate led by TD Securities Inc. The Notes are expected to be issued on April 30, 2026 and will bear interest at a fixed rate of 4.208% per annum (paid semi-annually) until June 16, 2031, and at Daily Compounded CORRA plus 1.27% thereafter (paid quarterly) until maturity on June 16, 2036. https://quantisnow.com/insight/td-bank-group-to-issue-nvcc-subordinated-debentures-6513257 https://quantisnow.com/insight/td-bank-group-to-issue-nvcc-subordinated-debentures-6513257 Thu, 23 Apr 2026 22:17:00 GMT -- Cash and Cash Investments at December 31, 2025 of €116.5 Million and Gross Proceeds of $208 Million from Initial Public Offering (IPO) Expected to Extend Cash Runway into First Half of 2029 -- -- Positive Interactions with U.S. Food and Drug Administration (FDA) on Design of Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease (FSCD) ---- On Track to Initiate Phase 2b Study in FSCD with Ontunisertib and Phase 2 Study in Idiopathic Pulmonary Fibrosis (IPF) with AGMB-447 in Second Half of 2026 ---- Topline Data from Open-Label Long-term Extension Study (OLE) Part of STENOVA Study with Ontunisertib in FSCD and from Phase 1b IPF Study Cohort with AGMB-447 Expected in Second Hal https://quantisnow.com/insight/agomab-reports-full-year-2025-financial-results-and-confirms-2026-6513253 https://quantisnow.com/insight/agomab-reports-full-year-2025-financial-results-and-confirms-2026-6513253 Thu, 23 Apr 2026 22:14:17 GMT Jefferies Financial Group Inc. (NYSE:JEF) ("JFG", "we" or "our") today announced the pricing of its public offering of $1.1 billion aggregate principal amount of 5.125% Senior Notes due 2031 (the "Notes") with an effective yield of 5.304%, maturing April 28, 2031. The offering is expected to settle on April 28, 2026, subject to the satisfaction of customary closing conditions. JFG intends to use the net proceeds of the offering for general corporate purposes. Jefferies LLC served as sole global co-ordinator and joint book-runner for the offering of the Notes, SMBC Nikko Securities America, Inc. served as joint book-runner, BNY Mellon Capital Markets, LLC, Citigroup Global Markets Inc. and https://quantisnow.com/insight/jefferies-financial-group-inc-announces-pricing-of-1100000000-5125-senior-6513229 https://quantisnow.com/insight/jefferies-financial-group-inc-announces-pricing-of-1100000000-5125-senior-6513229 Thu, 23 Apr 2026 21:44:00 GMT THE WOODLANDS, Texas, April 23, 2026 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality" or the "Company") (NASDAQ:TH), one of North America's largest providers of vertically-integrated modular accommodations and value-added hospitality services, today announced that it has closed its previously announced underwritten, secondary offering (the "Offering") of 8,050,000 shares of its common stock, par value $0.0001 per share (the "Common Stock"), held by Arrow Holdings S.à r.l. and MFA Global S.à r.l. (collectively, the "Selling Stockholders"), entities controlled by TDR Capital LLP, acting in its capacity as investment fund manager, at a price to the public of $14.00 per share, incl https://quantisnow.com/insight/target-hospitality-announces-closing-of-secondary-offering-and-full-exercise-6513017 https://quantisnow.com/insight/target-hospitality-announces-closing-of-secondary-offering-and-full-exercise-6513017 Thu, 23 Apr 2026 21:00:00 GMT BERRYVILLE, Va., April 23, 2026 /PRNewswire/ -- Eagle Financial Services, Inc. (NASDAQ:EFSI) (the "Company"), the holding company for Bank of Clarke, announced its first quarter 2026 results. Also, on April 23, 2026, the Board of Directors announced a quarterly common stock cash dividend of $0.31 per common share, payable on May 15, 2026, to shareholders of record on May 4, 2026. The following table presents selected financial performance highlights for the periods indicated: Three Months EndedMarch 31,December 31,March 31,202620252025(Dollars in thousands, except per share data https://quantisnow.com/insight/eagle-financial-services-inc-announces-2026-first-quarter-financial-results-6512897 https://quantisnow.com/insight/eagle-financial-services-inc-announces-2026-first-quarter-financial-results-6512897 Thu, 23 Apr 2026 20:35:00 GMT Lifezone Metals Limited (NYSE:LZM) announced today the closing of its previously announced1 share purchase agreement with institutional investors for the sale of 5,700,000 ordinary shares at a price of $4.40 per share. The offering raised approximately $25 million in gross proceeds to the Company, before deducting placement agent fees and offering-related expenses. The net proceeds of this offering will be used for exploration activities in Burundi and Tanzania, the PGM Recycling Project, conducting Hydromet research and development at Simulus Laboratory, and for other general corporate and working capital purposes, including financing costs. Current pre-FID, early-stage work, and project https://quantisnow.com/insight/lifezone-metals-announces-closing-of-25-million-registered-direct-offering-6512805 https://quantisnow.com/insight/lifezone-metals-announces-closing-of-25-million-registered-direct-offering-6512805 Thu, 23 Apr 2026 20:30:00 GMT SAN FRANCISCO, April 23, 2026 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR), a clinical-stage biotechnology company focused on development of novel immunology therapies, today announced the closing of its underwritten public offering of $373.8 million of shares of its common stock. Nektar sold 4,062,500 shares of common stock in the offering, which includes 529,891 shares sold upon exercise in full by the underwriters of their option to purchase additional shares of common stock in the offering. The shares of common stock were sold at a public offering price of $92.00 per share. The gross proceeds to Nektar from the offering were approximately $373.8 million, before deducting underwritin https://quantisnow.com/insight/nektar-therapeutics-announces-closing-of-3738-million-public-offering-including-6512611 https://quantisnow.com/insight/nektar-therapeutics-announces-closing-of-3738-million-public-offering-including-6512611 Thu, 23 Apr 2026 20:15:00 GMT TSXV: ITR; NYSE American: ITRG www.integraresources.comVANCOUVER, BC, April 23, 2026 /CNW/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV:ITR) (NYSE:ITRG) is pleased to provide an interim operational update for the first quarter ended March 31, 2026 (the "first quarter 2026" or "Q1 2026") highlighting continued operational momentum, record mining rates, and a strengthened balance sheet. The Company plans to release its first quarter 2026 financial results after market close on Monday May 11, 2026, followed by a conference call hosted by senior management on Tuesday https://quantisnow.com/insight/integra-announces-first-quarter-production-results-from-the-florida-canyon-6512396 https://quantisnow.com/insight/integra-announces-first-quarter-production-results-from-the-florida-canyon-6512396 Thu, 23 Apr 2026 20:05:00 GMT ISELIN, N.J., April 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) ("Outlook Therapeutics" or the "Company"), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 16,129,033 shares of its common stock at an offering price of $0.31 per share of common stock. Additionally, in a concurrent private placement, the Company issued unregistered warrants to purchase up to an aggregate of 16,129,033 shares of common stock at an exercise price https://quantisnow.com/insight/outlook-therapeutics-announces-closing-of-50-million-registered-direct-offering-6512344 https://quantisnow.com/insight/outlook-therapeutics-announces-closing-of-50-million-registered-direct-offering-6512344 Thu, 23 Apr 2026 20:05:00 GMT New York, New York, April 23, 2026 (GLOBE NEWSWIRE) -- ESH Acquisition Corp. (the "Company") (NASDAQ:ESHA) announced today that the Company received a notice (the "Deficiency Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") stating that the Company has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the "Form 10-K"), and therefore no longer complies with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission.  The Deficiency Notice stated that the Company has 60 calendar days to submit a plan to re https://quantisnow.com/insight/esh-acquisition-corp-announces-receipt-of-nasdaq-deficiency-letter-redemption-6512281 https://quantisnow.com/insight/esh-acquisition-corp-announces-receipt-of-nasdaq-deficiency-letter-redemption-6512281 Thu, 23 Apr 2026 20:01:00 GMT VANCOUVER, BC, April 23, 2026 /CNW/ - Cascadia Minerals Ltd. ("Cascadia") (TSXV:CAM) (OTCQB:CAMNF) is pleased to announce that it has closed its previously announced non-brokered private placement (the "Offering") with Agnico Eagle Mines Limited ("Agnico Eagle") (TSX:AEM) (NYSE:AEM) and certain other arms' length subscribers (the "Flow-Through Participants"). Unless otherwise indicated, all dollar amounts are stated in Canadian dollars. The Offering consisted of the issuance and sale of:19,315,300 units of Cascadia (the "Subscribed Units") to Agnico Eagle at a price of $0.26 per https://quantisnow.com/insight/cascadia-announces-closing-of-equity-investment-6512248 https://quantisnow.com/insight/cascadia-announces-closing-of-equity-investment-6512248 Thu, 23 Apr 2026 19:34:00 GMT Venture Global, Inc. (("Venture Global", NYSE:VG) announced today that its subsidiary, Venture Global Calcasieu Pass, LLC ("VGCP") has closed an offering of $750,000,000 aggregate principal amount of 6.000% senior secured notes due 2036 (the "Notes"). The Notes will mature on May 1, 2036. VGCP used the net proceeds from the offering, together with cash on hand and proceeds received from certain hedge terminations, for the prepayment, in full, of VGCP's outstanding term loans, and to pay fees and expenses in connection with the offering. The Notes are guaranteed by TransCameron Pipeline, LLC (VGCP's affiliate). The Notes are secured on a pari passu basis by a first-priority security intere https://quantisnow.com/insight/venture-global-announces-closing-of-750000000-senior-secured-notes-by-6512178 https://quantisnow.com/insight/venture-global-announces-closing-of-750000000-senior-secured-notes-by-6512178 Thu, 23 Apr 2026 17:47:00 GMT AUSTIN, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- Virtuix Inc. (NASDAQ:VTIX), a leading developer of full-body virtual reality systems, today announced that it will hold a virtual investor webinar on Friday, May 8, 2026, at 11:00 a.m. Eastern Time. Virtuix Chief Executive Officer Jan Goetgeluk will give an overview of the company's business and growth strategy, and discuss the company's recent commercial successes and developments, including its accelerating traction in the defense industry. Mr. Goetgeluk will be joined by Mr. David Allan, Virtuix's President and Chief Operating Officer, and Ms. Lauren Premo, Virtuix's Chief Marketing Officer. A question-and-answer session will follow. T https://quantisnow.com/insight/virtuix-to-host-virtual-investor-webinar-on-friday-may-8-6511875 https://quantisnow.com/insight/virtuix-to-host-virtual-investor-webinar-on-friday-may-8-6511875 Thu, 23 Apr 2026 12:47:00 GMT NEW YORK, April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced the pricing of an underwritten registered direct offering of 18,000,000 common shares at a purchase price of $1.00 per share, anchored by a $15M investment from a fundamental institutional investor with support from a large existing shareholder. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other e https://quantisnow.com/insight/lucid-diagnostics-announces-18-million-underwritten-offering-of-common-stock-6511815 https://quantisnow.com/insight/lucid-diagnostics-announces-18-million-underwritten-offering-of-common-stock-6511815 Thu, 23 Apr 2026 12:30:00 GMT RICHMOND, Va., April 23, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (NASDAQ:ARKO) (the "Company"), a Fortune 500 company and one of the largest convenience store operators in the United States, today announced that the Company will host a conference call on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2026. ARKO Corp.'s management team will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call. Date: Thursday, May 7, 2026Time: 9:00 a.m. Eastern TimeToll-free dial-in number: (877) 605-1792 International dial-in number: (201) 6 https://quantisnow.com/insight/arko-to-report-first-quarter-2026-financial-results-on-may-6511782 https://quantisnow.com/insight/arko-to-report-first-quarter-2026-financial-results-on-may-6511782 Thu, 23 Apr 2026 12:30:00 GMT LSI Industries Inc. (NASDAQ:LYTS, "LSI" or the "Company")) a leading U.S. based manufacturer of commercial lighting and display solutions, today reported results for the fiscal 2026 third quarter ended March 31, 2026. FISCAL 2026 THIRD QUARTER RESULTS Completed the acquisition of Royston Group on March 24, 2026 Net Sales of $150.5 million, +14% y/y; net sales excluding Royston +9% y/y Net Income $2.1 million; Adjusted Net Income $9.6 million, +52% y/y Diluted EPS of $0.06; Adjusted Diluted EPS of $0.28 EBITDA of $7.5 million; Adjusted EBITDA of $15.0 million, +34% y/y Ratio of net debt to TTM proforma Adjusted EBITDA 2.7x During the fiscal third quarter, LSI reported https://quantisnow.com/insight/lsi-industries-reports-fiscal-2026-third-quarter-results-and-declares-6511444 https://quantisnow.com/insight/lsi-industries-reports-fiscal-2026-third-quarter-results-and-declares-6511444 Thu, 23 Apr 2026 11:00:00 GMT Consolidated Net Sales Decline of 3.3% GAAP Diluted Loss Per Share of $2.41 Adjusted Diluted EPS(1) of $0.83 Cash Flow from Operations of $111.3 Million; Free Cash Flow(1)(2) of $103.1 Million   Initiates Fiscal 2027 Outlook: Consolidated Net Sales of $1.751-$1.822 Billion GAAP Diluted EPS of $3.57-$4.18; Adjusted Diluted EPS(1) of $3.25-$3.75 Adjusted EBITDA(1) of $190-$197 Million; Free Cash Flow(1)(2) of $85-$100 Million Helen of Troy Limited (NASDAQ:HELE) reported results for the three-month period ended February 28, 2026 and provided its outlook for fiscal 2027. Executive Summary – Fourth Quarter of Fiscal 2026 Compared to Fiscal 2025 Consolidated net sales revenue of $470.0 https://quantisnow.com/insight/helen-of-troy-reports-fourth-quarter-fiscal-2026-results-6511389 https://quantisnow.com/insight/helen-of-troy-reports-fourth-quarter-fiscal-2026-results-6511389 Thu, 23 Apr 2026 10:45:00 GMT STAFFORD, Texas, April 23, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that an abstract has been accepted for publication at the upcoming 2026 ASCO Annual Meeting along with a corresponding poster presentation. The 2026 ASCO Annual Meeting will be held from May 28 to June 2, 2026. The full text of the abstract and poster will be available on June 1, 2026, the day of the presentation. CEO Snehal Patel commented, " We look forward to https://quantisnow.com/insight/greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026-6511215 https://quantisnow.com/insight/greenwich-lifesciences-announces-acceptance-of-abstract-at-asco-2026-6511215 Thu, 23 Apr 2026 10:00:00 GMT L3Harris Technologies (NYSE:LHX) has closed a $1 billion strategic investment from the Department of War (DoW) in its Missile Solutions (MSL) business, which it will use to expand and modernize facilities, accelerate research and development, and increase production capacity for critical national security technologies. The investment from the DoW is in the form of a convertible preferred security of the MSL business, which will convert into common equity upon an initial public offering (IPO). In addition, the DoW will receive certain warrants to purchase common stock in MSL. As previously announced, L3Harris intends to pursue an IPO of MSL in the second half of 2026, pending market condit https://quantisnow.com/insight/l3harris-closes-1b-investment-from-department-of-war-in-missile-6511211 https://quantisnow.com/insight/l3harris-closes-1b-investment-from-department-of-war-in-missile-6511211 Thu, 23 Apr 2026 10:00:00 GMT GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced the pricing of its previously announced underwritten public offering consisting of (i) 64,250,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 64,250,000 shares of common stock (or pre-funded warrants in lieu thereof) and (ii) in lieu of common stock, to certain investors that so choose, pre-funded warrants to purchase an aggregate of up to 10,750,000 shares of its common stock and accompanying common stock warrants to purchase an aggregat https://quantisnow.com/insight/altimmune-announces-pricing-of-225-million-oversubscribed-public-offering-of-6511183 https://quantisnow.com/insight/altimmune-announces-pricing-of-225-million-oversubscribed-public-offering-of-6511183 Thu, 23 Apr 2026 03:25:00 GMT STAFFORD, Texas, April 22, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated GLSI-100, an immunotherapy to prevent breast cancer recurrences, today announced that on April 16, 2026, the Company received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, because it has not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, the Company is not currently in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely https://quantisnow.com/insight/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-6510835 https://quantisnow.com/insight/greenwich-lifesciences-announces-receipt-of-nasdaq-notice-regarding-late-form-6510835 Wed, 22 Apr 2026 21:00:00 GMT GAITHERSBURG, Md., April 22, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ:ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced it has commenced an underwritten public offering of shares of its common stock and accompanying common stock warrants to purchase an equivalent number of shares of its common stock (or pre-funded warrants in lieu thereof), and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock and accompanying common stock warrants to purchase shares of its common stock (or pre-funded warrants in lieu thereof). All of the shares, pre-funded warrants https://quantisnow.com/insight/altimmune-announces-proposed-underwritten-public-offering-of-securities-6510535 https://quantisnow.com/insight/altimmune-announces-proposed-underwritten-public-offering-of-securities-6510535 Wed, 22 Apr 2026 20:19:41 GMT AXT, Inc. (NASDAQ:AXTI) ("AXT" or the "Company"), a leading manufacturer of compound semiconductor wafer substrates, announced today the closing of its underwritten public offering of 8,560,311 shares of common stock at a price to the public of $64.25 per share. The Company received total gross proceeds of approximately $550 million, before deducting the underwriting discounts and commissions and other offering expenses. In addition, the Company granted the underwriter a 30-day option to purchase up to 1,284,046 additional shares of common stock at the public offering price, less the underwriting discounts (the "Overallotment Option"). If the Overallotment Option is fully exercised, the Com https://quantisnow.com/insight/axt-announces-closing-of-public-offering-of-common-stock-6510237 https://quantisnow.com/insight/axt-announces-closing-of-public-offering-of-common-stock-6510237 Wed, 22 Apr 2026 20:05:00 GMT - Expands Committed Investment Pipeline to More than $125 Million - - Increases 2026 Full Year Earnings Guidance - NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Getty Realty Corp. (NYSE:GTY) ("Getty" or the "Company"), a net lease REIT focused on convenience and automotive retail real estate, announced today its financial and operating results for the quarter ended March 31, 2026. First Quarter 2026 Highlights Net earnings: $0.43 per shareFunds From Operations ("FFO"): $0.69 per shareAdjusted Funds From Operations ("AFFO"): $0.63 per shareInvested $30.3 million across 29 properties at an 8.0% initial cash yieldExtended leases totaling $11.3 million, or 5.0% of annualized base rent (ABR) https://quantisnow.com/insight/getty-realty-corp-announces-first-quarter-2026-results-6510208 https://quantisnow.com/insight/getty-realty-corp-announces-first-quarter-2026-results-6510208 Wed, 22 Apr 2026 20:05:00 GMT SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ:BLTE) a clinical stage development company based in San Diego and focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Hendrick Scholl, Chief Medical Officer, will present at the Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference (dbVIC) on April 28th, 2026. This virtual investor conference is aimed exclusively at introducing global companies with ADR programs to investors. Details of the presentation are as follows: DATE: April 28th TIME: 9:00 a.m. ET REGISTER HERE This will be a live, interactive o https://quantisnow.com/insight/belite-bio-to-present-at-the-deutsche-bank-american-depositary-6509698 https://quantisnow.com/insight/belite-bio-to-present-at-the-deutsche-bank-american-depositary-6509698 Wed, 22 Apr 2026 12:35:00 GMT NEW YORK, April 22, 2026 /PRNewswire/ -- Kerrisdale Capital Management, LLC and Steamboat Capital Partners, LLC today sent a letter to the CEO and Board of Directors of ACM Research, Inc.  The full text of the letter follows:April 22, 2026David H. WangChief Executive OfficerACM Research, Inc.42307 Osgood Road, Suite IFremont, CA  94539cc: Board of DirectorsDear David,Kerrisdale Capital Management, LLC, Steamboat Capital Partners LLC and our respective affiliates collectively own or advise entities owning approximately 600,000 shares of ACM Research, Inc. We are excited to hear that management is taking preliminary steps to pursue a Hong Kong share listing, per your Form 8-K filed with the Se https://quantisnow.com/insight/kerrisdale-and-steamboat-send-letter-to-acm-research-inc-6509685 https://quantisnow.com/insight/kerrisdale-and-steamboat-send-letter-to-acm-research-inc-6509685 Wed, 22 Apr 2026 12:30:00 GMT CHARLOTTE, N.C., April 22, 2026 /PRNewswire/ -- Honeywell (NASDAQ:HON) today announced that Quantinuum LLC ("Quantinuum" or the "Company"), which is majority owned by Honeywell, confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission (the "SEC") on February 17, 2026, relating to the proposed initial public offering of Quantinuum's common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process. https://quantisnow.com/insight/honeywell-announces-quantinuums-confidential-submission-of-draft-registration-statement-for-6509679 https://quantisnow.com/insight/honeywell-announces-quantinuums-confidential-submission-of-draft-registration-statement-for-6509679 Wed, 22 Apr 2026 12:30:00 GMT